Taken together, the findings reinforce the role of SR-A and MCP-1 in endothelial dysfunction in RA and warrant further studies in relation to the therapeutic exploitation of this interaction under biological DMARD usage. The gene discussed is SRA1; the disease is rheumatoid arthritis.